According to public databases, and as previously described by Manzano et al. (2021), RAPGEF1 mRNA levels are decreased in GBM patients compared to healthy brain tissue (Figure 3), although this is not associated with changes in overall survival [63], as occurs in other tumours. This evidence concerns the gene RAPGEF1 and neoplasm.